IOVANCE BIOTHERAPEUTICS, INC. (IOVA) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 165 transactions totaling $159.7M, demonstrating a bullish sentiment with $159.7M in net insider flow. The most recent transaction on Dec 2, 2025 involved a transaction of 4,426 shares valued at $9.5K.
No significant insider buying has been recorded for IOVA in the recent period.
No significant insider selling has been recorded for IOVA in the recent period.
Based on recent SEC filings, insider sentiment for IOVA is bullish with an Insider Alignment Score of 100/100 and a net flow of $159.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at IOVANCE BIOTHERAPEUTICS, INC. (IOVA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading IOVA stock, having executed 165 transactions in the past 90 days. The most active insider is Wayne P. Rothbaum (Executive), who has made 7 transactions totaling $156.3M.
Get notified when executives and directors at IOVA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | G. Vogt Frederick | Executive | Payment | 4,426 | $2.14 | $9.5K | |
| Dec 2, 2025 | G. Vogt Frederick | Executive | Option Exercise | 10,417 | $N/A | $0 | |
| Dec 2, 2025 | Bilinsky Igor | Executive | Option Exercise | 3,516 | $N/A | $0 | |
| Dec 2, 2025 | Bilinsky Igor | Executive | Payment | 1,786 | $2.14 | $3.8K | |
| Dec 2, 2025 | Friedrich Graf Finckenstein | Executive | Option Exercise | 3,906 | $N/A | $0 | |
| Dec 2, 2025 | Friedrich Graf Finckenstein | Executive | Payment | 1,984 | $2.14 | $4.2K | |
| Dec 1, 2025 | K. Puri Raj | Executive | Option Exercise | 5,469 | $N/A | $0 | |
| Dec 1, 2025 | K. Puri Raj | Executive | Payment | 2,467 | $2.23 | $5.5K | |
| Dec 1, 2025 | G. Vogt Frederick | Executive | Payment | 17,701 | $2.23 | $39.5K | |
| Dec 1, 2025 | G. Vogt Frederick | Executive | Option Exercise | 41,669 | $N/A | $0 | |
| Dec 1, 2025 | Bilinsky Igor | Executive | Payment | 4,464 | $2.23 | $10.0K | |
| Dec 1, 2025 | Bilinsky Igor | Executive | Option Exercise | 8,789 | $N/A | $0 | |
| Dec 1, 2025 | Friedrich Graf Finckenstein | Executive | Payment | 4,464 | $2.23 | $10.0K | |
| Dec 1, 2025 | Friedrich Graf Finckenstein | Executive | Option Exercise | 8,789 | $N/A | $0 | |
| Sep 2, 2025 | Bilinsky Igor | Executive | Option Exercise | 12,306 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 23 | $159.7M | 97.0% |
Payment(F) | 89 | $4.6M | 2.8% |
Exercise(M) | 52 | $226.0K | 0.1% |
Gift(G) | 1 | $0 | 0.0% |
Insiders at IOVANCE BIOTHERAPEUTICS, INC. are accumulating shares at an accelerated pace. With 11 insiders making 165 transactions totaling $159.7M in purchases versus $0 in sales, the net buying activity of $159.7M signals strong executive confidence. Wayne P. Rothbaum (Executive) leads the buying activity with $156.3M in transactions across all time.